InfuSystem (NYSEAMERICAN:INFU) Share Price Passes Above 200-Day Moving Average of $0.00

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU - Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $8.89. InfuSystem shares last traded at $8.81, with a volume of 71,942 shares traded.

InfuSystem Trading Down 5.9 %

The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.66 and a current ratio of 2.08. The company has a market capitalization of $175.58 million, a price-to-earnings ratio of 276.43 and a beta of 1.24.

Hedge Funds Weigh In On InfuSystem

Institutional investors have recently made changes to their positions in the stock. Panagora Asset Management Inc. boosted its position in shares of InfuSystem by 1.7% in the first quarter. Panagora Asset Management Inc. now owns 87,948 shares of the medical instruments supplier's stock worth $862,000 after acquiring an additional 1,508 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of InfuSystem by 31.3% in the 1st quarter. Bank of America Corp DE now owns 6,398 shares of the medical instruments supplier's stock valued at $50,000 after purchasing an additional 1,526 shares during the last quarter. Royal Bank of Canada grew its stake in shares of InfuSystem by 4.4% during the 2nd quarter. Royal Bank of Canada now owns 40,086 shares of the medical instruments supplier's stock valued at $386,000 after buying an additional 1,676 shares during the period. State Street Corp increased its holdings in shares of InfuSystem by 3.8% during the 1st quarter. State Street Corp now owns 68,631 shares of the medical instruments supplier's stock worth $532,000 after buying an additional 2,500 shares during the last quarter. Finally, Marshall Wace LLP raised its position in shares of InfuSystem by 8.5% in the 3rd quarter. Marshall Wace LLP now owns 33,599 shares of the medical instruments supplier's stock worth $235,000 after buying an additional 2,625 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.